MedPath

Effects of monthly consumption of 100000 unit cholecalciferol during last third trimester of pregnancy on plasma iPTH and 25 (OH) D3 of the mother and cord blood

Phase 2
Conditions
Vit D.
Fetus and newborn affected by maternal nutritional disorders
Registration Number
IRCT201104306335N1
Lead Sponsor
Vice chancellor for endocrine research, Shahid Beheshty University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
25
Inclusion Criteria

Pregnant women whose gestational age was between 27 to 28 weeks.
Exclusion criteria: Patients with systemic diseases such as renal (Cr > 2) and known liver disease, sarcoidosis, tuberculosis and receiving of vit D and anticonvulsant drugs.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
25(0H)Vit D. Timepoint: 3 months. Method of measurement: Laboratory methods( ng/ml ).;IPTH. Timepoint: 3 months. Method of measurement: Laboratory methods(Pmol/l).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath